Diabetic osteopenia: Pathophysiology and clinical aspects
- 1 April 1995
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 11 (1) , 21-35
- https://doi.org/10.1002/dmr.5610110103
Abstract
No abstract availableThis publication has 80 references indexed in Scilit:
- Possible involvement of vitamin D3-deficiency and relatively enhanced bone resorption in the development of bone loss in streptozotocin-induced diabetic ratsLife Sciences, 1994
- Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolismBiochemical and Biophysical Research Communications, 1989
- Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3Biochemistry, 1988
- The difference of biological activity among four diastereoisomers of 1α,25-dihydroxycholecalciferol-26,23-lactoneThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Calcitonin secreting property of ipriflavone in the presence of estrogenLife Sciences, 1986
- Vitamin D metabolism in insulin-dependent diabetes mellitusMetabolic Bone Disease and Related Research, 1982
- Diabetes Mellitus and Risk of Skeletal FractureNew England Journal of Medicine, 1980
- The Peripheral Metabolism of Parathyroid HormoneNew England Journal of Medicine, 1979
- Urinary Calcium Excretion in Human BeingsNew England Journal of Medicine, 1979
- Experimental Diabetes Reduces Circulating 1,25-Dihydroxyvitamin D in the RatScience, 1977